DE950638C - Process for making new pyrazolones - Google Patents

Process for making new pyrazolones

Info

Publication number
DE950638C
DE950638C DEC6607A DEC0006607A DE950638C DE 950638 C DE950638 C DE 950638C DE C6607 A DEC6607 A DE C6607A DE C0006607 A DEC0006607 A DE C0006607A DE 950638 C DE950638 C DE 950638C
Authority
DE
Germany
Prior art keywords
cyclopentenyl
pyrazolones
pyrazolone
phenyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DEC6607A
Other languages
German (de)
Inventor
Dr Karl Burschkies
Dr Walther Persch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cassella Farbwerke Mainkur AG
Original Assignee
Cassella Farbwerke Mainkur AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur AG filed Critical Cassella Farbwerke Mainkur AG
Priority to DEC6607A priority Critical patent/DE950638C/en
Application granted granted Critical
Publication of DE950638C publication Critical patent/DE950638C/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/261-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Description

Verfahren zur Herstellung neuer Pyrazolone Pyrazolone mit Cyclopentenyl- bzw. Cyclopentylresten sind bisher nicht bekanntgeworden. Es hat sich nun gezeigt, daß solche gemäß nachstehender Formelschemata C6Hs C6H5 C00 - C2H5 N C0 NH + CH,-CO-CH-< I CH, -C CH-` I 14 H2 i-Phenyl-3-methyl-q.-cyclopentenyl-g-pyrazolon CGH5 /N\ 5H5 i 00 . C,H, Alkyl [ @ O NH -E- CH,-CO-C11-@ CH3-C C-@ i NH - Alkyl 1-Phenyl-2-alkyl-3-methyl-4-cyclopentyl-5-pyrazolon durchKondensationvon a-Cyclopentenyl-bzw. a-Cyclopentylacetessigester (deren Herstellung in »Archiv der Pharmazie« 279 [194r], S.47, und 281 [r943], S. 332, beschrieben ist) mit Phenylhydrazin bzw. mit N-Al$yl-N'-phenylhydrazinen nach an sich bekannter Methode erhältlichen Pyrazolone - die also in 4-Stellung des Pyrazolonkerns den Cyclopentenyl-bzw. Cyclopentylrest tragen - besonders gute Antiphlogistika sind. Sie übertreffen in dieser Beziehung die bekannten Pyrazolone ähnlicher Konstitution, welche in 4-Stellung an Stelle des Cyclopentenyl- bzw. Cyclopentylrestes eine Alkylgruppe enthalten.Process for the production of new pyrazolones Pyrazolones with cyclopentenyl or cyclopentyl radicals have not yet become known. It has now been shown that such according to the following formula schemes C6Hs C6H5 C00 - C2H5 N C0 NH + CH, -CO-CH- <I CH, -C CH-`I 14 H2 i-phenyl-3-methyl-q.-cyclopentenyl-g-pyrazolone CGH5 / N \ 5H5 i 00. C, H, alkyl [@ O NH -E- CH, -CO-C11- @ CH3-C C- @ i NH - alkyl 1-phenyl-2-alkyl-3-methyl-4-cyclopentyl-5-pyrazolone by condensation of a-cyclopentenyl or. a-Cyclopentylacetoacetic ester (the preparation of which is described in "Archiv der Pharmazie" 279 [194r], p.47, and 281 [r943], p. 332) with phenylhydrazine or with N-Al $ yl-N'-phenylhydrazines pyrazolones obtainable by a known method - that is, in the 4-position of the pyrazolone nucleus, the cyclopentenyl or. Carrying cyclopentyl radicals - are particularly good anti-inflammatory drugs. In this respect they surpass the known pyrazolones of a similar constitution, which contain an alkyl group in the 4-position instead of the cyclopentenyl or cyclopentyl radical.

Die nach dem geschilderten Verfahren aus Phenylhydrazin und a-Cyclopentenyl- bzw_ a-Cyclopentylacetessigester zugänglichen 1-Phenyl-3-methyl-4-cyclopentenyl- bzw. 4-cyclopentylpyrazolone lassen sich mit den üblichen Alkyherungsmethoden nach dem Formelschema C,H, C6H5 /N\ /N\ O @ ---@ Alkyl- N CH3C CH CH, -C C-<:7 1-Phenyl-3-methyl-4-cyclopentenyl-5-pyrazolon 1-Phenyl-2-alkyl-3-methyl-4-cyclopentenyl-5-pyrazolon in die entsprechenden 2-Alkylpyrazolone überführen. Letztere Verbindungen sind identisch mit den schon obenerwähnten, aus dem zugehörigen N-Alkyl-N'-phenylhydrazin durch Kondensation mit a-Cyclopentenyl- bzw. a-Cyclopentylacetessigester direkt herstellbaren Pyrazolonderivaten.The 1-phenyl-3-methyl-4-cyclopentenyl- or 4-cyclopentylpyrazolones, which can be obtained from phenylhydrazine and a-cyclopentenyl or a-cyclopentylacetoacetic ester, can be obtained using the usual alkylation methods according to the formula scheme C, H, C6H5 / N \ / N \ O @ --- @ alkyl- N CH3C CH CH, -C C- <: 7 1-phenyl-3-methyl-4-cyclopentenyl-5-pyrazolone 1-phenyl-2-alkyl-3-methyl-4-cyclopentenyl-5-pyrazolone Convert into the corresponding 2-alkylpyrazolones. The latter compounds are identical to the above-mentioned pyrazolone derivatives which can be prepared directly from the associated N-alkyl-N'-phenylhydrazine by condensation with α-cyclopentenyl or α-cyclopentylacetacetic ester.

Beispiel 1 54 g Wisch destilliertes Phenylhydrazin werden mit 98,6 g Cyclopentenylacetessigsäureäthylester unter Rühren im Rundkolben langsam auf 14o° erhitzt und 3 Stunden auf dieser Temperatur gehalten. Das Reaktionsgemisch verrührt man nach dem Erkalten mit 300 ccm Äther, gießt den Äther vom Ungelösten ab, wäscht den Rückstand mit kaltem Äther nach, trocknet ihn und kristallisiert ihn aus verdünntem Alkohol um. Man erhält so i-Phenyl-3-methyl-4-cyclopentenyl-5-pyrazolon vom F. 135°.EXAMPLE 1 54 g of wipingly distilled phenylhydrazine are slowly heated to 140 ° with 98.6 g of ethyl cyclopentenylacetoacetate while stirring in a round bottom flask and kept at this temperature for 3 hours. After cooling, the reaction mixture is stirred with 300 cc of ether, the undissolved substance is poured off the ether, the residue is washed with cold ether, dried and recrystallized from dilute alcohol. This gives i-phenyl-3-methyl-4-cyclopentenyl-5-pyrazolone with a melting point of 135 °.

Beispiel 2 549 Phenylhydrazin werden mit Zoo g Cyclopentylacetessigsäureäthylester 3 Stunden auf 140° erhitzt. Die Reaktionsmasse verreibt man nach dem Erkalten mit 4oo ccm Äther, wobei man das Kondensationsprodukt als festen, ätherunlöslichen Rückstand erhält. Dieser wird auf übliche Weise abgetrennt, mit kaltem Äther gewaschen, getrocknet und aus Methanol umkristallisiert. Das so gereinigte 1-Phenyl-3-methyl-4-cyclopentyl-5-pyrazolon hat den Schmelzpunkt 136°.Example 2 549 phenylhydrazine are mixed with zoo g of ethyl cyclopentylacetoacetate Heated to 140 ° for 3 hours. The reaction mass is rubbed in after cooling 400 ccm of ether, whereby the condensation product is a solid, ether-insoluble residue receives. This is separated off in the usual way, washed with cold ether and dried and recrystallized from methanol. The 1-phenyl-3-methyl-4-cyclopentyl-5-pyrazolone purified in this way has a melting point of 136 °.

Beispiel 3 66 g ß-Methylphenylhydrazin werden mit Zoo g Cyclopentylacetessigsäureäthylester -im Ölbad unter lebhaftem Rühren 3 Stunden auf 14o° erhitzt. Das rohe Kondensationsprodukt verreibt man nach dem Erkalten mit 3oo ccm Äther, gießt den Äther ab, wäscht den Rückstand mit wenig kaltem Äther nach und trocknet ihn. Das so erhaltene 1-Phenyl-a, 3-dimethyl-4-cyclopentyl-5-pyrazolon wird durch Destillation im Hochvakuum gereinigt. Es hat einen Siedepunkt von 195 bis 200°/0,5 mm und schmilzt-bei Z26°. Beispiel 4 20 g Z-Phenyl-3-methyl-4-cyclopentenyl-5-pyrazolon werden in 2o ccm Methanol gelöst und mit 2o g Jodmethyl im Bombenrohr 6 Stunden auf iio° erhitzt. Das Reaktionsgemisch nimmt man in Methanol auf und entfärbt die Lösung mit Tierkohle. Das Methanol wird sodann abdestilliert, der Rückstand, welcher das Jodhydrat der methylierten Base enthält, in Wasser gelöst und mit verdünnter Natronlauge versetzt, wobei die freie Base ausfällt. - Diese trennt man durch Ausschütteln mit Chloroform von der wäßrigen Flüssigkeit ab und unterwirft sie nach Entfernen des Lösungsmittels der Hochvakuumdestillation. Man erhält so i-Phenyl-2, 3-dimethyl-q -cyclopentenyl-5-pyrazolon als 01 vom Siedepunkt 185°/o,3 mm, das beim Abkühlen zu Kristallen erstarrt. 'EXAMPLE 3 66 g of β-methylphenylhydrazine are heated with zoo g of ethyl cyclopentylacetoacetate in an oil bath for 3 hours with vigorous stirring. After cooling, the crude condensation product is triturated with 300 cc of ether, the ether is poured off, the residue is washed with a little cold ether and is dried. The 1-phenyl-α, 3-dimethyl-4-cyclopentyl-5-pyrazolone obtained in this way is purified by distillation in a high vacuum. It has a boiling point of 195 to 200 ° / 0.5 mm and melts at Z26 °. EXAMPLE 4 20 g of Z-phenyl-3-methyl-4-cyclopentenyl-5-pyrazolone are dissolved in 20 cc of methanol and heated to 10 ° for 6 hours with 20 g of iodomethyl in a sealed tube. The reaction mixture is taken up in methanol and the solution is decolorized with animal charcoal. The methanol is then distilled off, the residue, which contains the iodine hydrate of the methylated base, is dissolved in water and mixed with dilute sodium hydroxide solution, the free base precipitating out. - These are separated from the aqueous liquid by shaking with chloroform and, after removing the solvent, subjected them to high vacuum distillation. Is obtained as i-phenyl-2, 3-dimethyl-q -cyclopentenyl-5-pyrazolone as 01 of boiling point 185 ° / o, 3 mm, which solidifies to form crystals upon cooling. '

Claims (1)

PATENTANSPRUCIi: Verfahren zur Herstellung neuer Pyrazolone, dadurch gekennzeichnet, daß man nach an sich bekannter Methode a-Cyclopentenyl- bzw. a-Cyclopentylacetessigsäureester mit Phenylhydrazin oder mit N-Alkyl-N'=phenylhydrazinen kondensiert und die erhaltenen Produkte gegebenenfalls mit alkylierenden Mitteln behandelt.PATENT CLAIMS: Process for the production of new pyrazolones, thereby characterized in that a-cyclopentenyl or a-cyclopentylacetoacetic acid ester is used according to a method known per se condensed with phenylhydrazine or with N-alkyl-N '= phenylhydrazines and the obtained Products treated with alkylating agents if necessary.
DEC6607A 1952-11-04 1952-11-04 Process for making new pyrazolones Expired DE950638C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DEC6607A DE950638C (en) 1952-11-04 1952-11-04 Process for making new pyrazolones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEC6607A DE950638C (en) 1952-11-04 1952-11-04 Process for making new pyrazolones

Publications (1)

Publication Number Publication Date
DE950638C true DE950638C (en) 1956-10-11

Family

ID=7013946

Family Applications (1)

Application Number Title Priority Date Filing Date
DEC6607A Expired DE950638C (en) 1952-11-04 1952-11-04 Process for making new pyrazolones

Country Status (1)

Country Link
DE (1) DE950638C (en)

Similar Documents

Publication Publication Date Title
DE1445878A1 (en) Process for the preparation of benzodiazepine derivatives
DE950638C (en) Process for making new pyrazolones
DE1670478A1 (en) Process for the preparation of derivatives of alpha-piperazino-phenylacetonitrile
DEC0006607MA (en)
CH320584A (en) Process for making new pyrazolones
DE2156501A1 (en) 5,6-benzo-gamma-pyridone derivs - inters for anticarcinogenic cpds
DE2412323C3 (en) 1,2-Diphenyl ether derivatives, processes for their preparation and pharmaceuticals containing them
DE960538C (en) Process for the preparation of 5-benzyloxy-ª,2-dinitrostyrenes
DE1966132B2 (en) 7-chloro-2-hydroxy-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepine
DE670968C (en) Process for the preparation of 2-alkylhexahydrobenzothiazoles and 2-alkylhexahydrobenzoselenazoles
DE611692C (en) Process for the preparation of cyclically disubstituted tetrazoles
AT240373B (en) Process for the preparation of benzodiazepine derivatives
DE897406C (en) Process for the preparation of pyrazolone compounds
AT218531B (en) Process for the preparation of the new N- (4-sulfonamidophenyl) -butanesultam
DE954872C (en) Process for the preparation of dithiocarbamic acid esters
DE908020C (en) Process for the preparation of 2-aminopyridine compounds
DE650431C (en) Process for the preparation of trisubstituted barbituric acids
AT217994B (en) Process for the preparation of new derivatives of polyhydroxy alcohols
AT201248B (en) Process for the preparation of the new 6-hydroxy-3: 5-cyclopregnan-20-one
DE1076136B (en) Process for the preparation of 3, 5-disubstituted 1, 2, 4-triazoles
DE1167849B (en) Process for the preparation of N&#39;-isopropyl-N-acylhydrazides
DE670420C (en) Process for the preparation of sulfonaethylamines
DE870552C (en) Process for the preparation of new amidine salts
DE962431C (en) Process for the preparation of substituted boric acid tricyclohexyl esters
DE568549C (en) Process for the preparation of 2-alkoxy-5-nitropyridines